Mandatory notification of trade

Reference is made to the announcement today from Vistin Pharma ASA ("Vistin
Pharma") regarding the final result of the subsequent repair issue.  Vegard
Heggem, VP Operations, has been allocated 10,000 new shares at a subscription
price of NOK 11.20 per share. After this transaction Vegard Heggem will
hold 27,360 shares in Vistin Pharma.